New draft guidance from the FDA is urging pharma companies to accelerate efforts to transition from animal testing to non-animal alternatives. The document is intended to help companies validate 'new ...
The EU medicines regulator has backed a proposal designed to reduce the use of animals in medicines development by replacing them with virtual models. Specifically, the proposal covers the use of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results